YOLFTbeta
00

Zhejiang Xianju Pharmaceutical Co Ltd

002332 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

8.60CNY-0.01 (-0.12%)

Price History

Full chart

Market Stats

Previous Close8.61
Open8.61
Day Range8.56 – 8.73
52-Week Range7.83 – 9.70
Volume13.35M
Market Cap8.55B
P/E (TTM)22.15
Forward P/E28.41
EPS0.39
Dividend Yield3.47%
Beta0.18
50-Day Avg8.58
200-Day Avg8.80

About

Zhejiang Xianju Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers cortical steriod, gynecology and family planning, respiratory, and dermatological drugs, as well as anaesthetic and muscle relaxants; and active pharmaceutical ingredients and intermediates. It is also involved in the provision of contract development and manufacturing organization; contract manufacturing organization; technical; technology development; and inspection and testing services. The company was founded in 1972 and is headquartered in Xianju, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Weihua Jin
  • Employees3.21K
  • HeadquartersNo. 15, Fengxi West Road, Xianju, China, 317306, China
  • Websitehttps://www.xjpharma.com

Leadership

  • Mr. Weihua JinGM & Director · b. 1975
  • Ms. Yao Hua WangChief Financial Officer · b. 1971
  • Mr. Wangwei ZhangDeputy GM & Secretary · b. 1982
  • Mr. Carlo CartasegnaDeputy General Manager · b. 1959
  • Mr. Wen Hui ZouDeputy General Manager · b. 1977

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue765.33M966.79M1.13B1.28B1.50B1.69B1.99B2.32B2.47B2.48B2.50B2.85B3.62B3.71B4.02B4.36B4.38B4.12B4.00B3.76B
Growth (%)-+26.32%+17.25%+12.63%+17.57%+12.54%+17.94%+16.21%+6.72%+0.39%+0.95%+13.93%+26.97%+2.40%+8.37%+8.42%+0.52%-5.85%-2.98%-6.04%
Cost of Revenue492.50M594.76M696.53M742.83M926.48M1.01B1.21B1.52B1.52B1.41B1.24B1.26B1.49B1.48B1.80B1.85B1.86B1.97B1.74B1.46B
Gross Profit272.83M372.02M436.98M533.89M574.50M679.42M778.50M791.50M947.09M1.07B1.27B1.59B2.13B2.23B2.22B2.51B2.51B2.15B2.26B2.30B
Gross Margin35.65%38.48%38.55%41.82%38.27%40.22%39.08%34.19%38.34%43.05%50.63%55.73%58.79%60.18%55.18%57.58%57.42%52.18%56.40%61.19%
Operating Expense201.75M277.09M356.77M393.00M425.99M515.86M590.77M676.31M877.99M951.43M1.09B1.29B1.70B1.69B1.62B1.75B1.64B1.51B1.58B1.81B
Operating Income71.08M94.93M80.21M140.89M148.51M163.56M187.74M115.19M69.11M116.24M176.25M297.64M431.25M543.40M597.24M758.65M878.60M646.46M678.21M490.12M
Operating Margin9.29%9.82%7.08%11.04%9.89%9.68%9.42%4.98%2.80%4.69%7.04%10.43%11.91%14.65%14.86%17.41%20.06%15.68%16.95%13.04%
EBITDA115.27M139.68M166.24M186.99M206.29M232.82M229.33M176.46M208.10M250.12M283.58M431.91M605.18M697.36M817.16M857.11M866.26M816.24M835.24M763.05M
EBITDA Margin15.06%14.45%14.67%14.65%13.74%13.78%11.51%7.62%8.42%10.08%11.33%15.14%16.71%18.80%20.33%19.67%19.78%19.80%20.88%20.30%
Net Income49.53M64.64M65.04M88.84M120.17M132.87M120.56M60.59M56.70M106.55M146.19M206.63M301.36M410.37M504.51M619.33M749.41M563.08M397.18M449.64M
Net Income Margin6.47%6.69%5.74%6.96%8.01%7.87%6.05%2.62%2.29%4.30%5.84%7.24%8.32%11.07%12.55%14.21%17.11%13.66%9.93%11.96%
R&D----48.25M49.19M60.03M79.67M88.41M86.50M87.14M88.15M142.85M204.52M208.39M243.37M266.77M261.00M268.76M303.75M
R&D as % of Total Revenue----3.21%2.91%3.01%3.44%3.58%3.49%3.48%3.09%3.94%5.51%5.19%5.59%6.09%6.33%6.72%8.08%
Interest Expense27.10M33.51M46.31M35.60M26.41M29.17M43.06M54.21M67.30M66.54M41.40M56.77M86.04M71.69M69.41M32.11M12.27M6.64M5.77M4.64M
Interest Expense % of Total Revenue3.54%3.47%4.09%2.79%1.76%1.73%2.16%2.34%2.72%2.68%1.65%1.99%2.38%1.93%1.73%0.74%0.28%0.16%0.14%0.12%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets984.32M1.05B1.15B1.88B1.82B2.01B2.44B2.75B2.80B3.44B3.62B5.13B5.44B5.82B6.84B6.72B6.74B6.99B7.00B7.26B
Total Liabilities593.35M644.44M747.44M778.28M701.29M860.02M1.24B1.57B1.57B1.29B1.38B2.75B2.73B2.77B2.26B1.78B1.23B1.16B1.11B1.18B
Total Equity362.39M375.53M382.20M1.08B1.11B1.12B1.16B1.16B1.21B2.14B2.23B2.35B2.63B2.94B4.44B4.83B5.46B5.79B5.84B6.04B
Cash124.41M134.09M153.62M812.43M689.08M437.24M304.87M290.10M305.04M513.31M488.12M911.32M892.49M1.03B1.44B1.27B1.72B1.66B1.38B1.20B
Total Debt393.80M438.89M564.25M545.51M458.09M489.77M585.36M842.59M902.46M639.83M540.91M1.92B1.77B1.77B1.18B739.25M344.42M445.56M39.29M-
Net Debt269.39M304.81M410.63M-266.92M-230.99M52.54M280.49M552.49M597.42M126.52M52.79M1.01B879.43M743.77M-259.33M-527.72M-1.38B-1.21B-1.34B-

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow53.05M96.53M36.03M104.68M155.29M147.63M33.43M63.46M141.64M199.61M155.91M167.47M193.27M519.81M789.23M676.15M609.28M595.48M398.66M247.48M
Investing Cash Flow-9.99M-15.00M-50.15M-17.91M-52.13M-274.51M-331.15M-179.59M-104.14M-479.09M-36.01M-674.65M72.71M-211.36M-574.59M-222.94M358.07M-199.63M-180.42M-
Financing Cash Flow-28.57M-43.52M19.63M578.83M-224.32M-124.95M165.65M113.00M-11.92M475.17M-198.31M673.78M-293.30M-166.65M309.92M-484.13M-422.44M-463.85M-465.82M-
Capital Expenditure36.51M67.55M59.25M42.94M62.58M274.14M298.01M189.26M108.26M115.05M97.10M123.28M169.26M262.34M118.17M266.84M282.54M234.63M207.59M209.07M
Free Cash Flow16.54M28.99M-23.22M61.74M92.71M-126.51M-264.58M-125.80M33.38M84.56M58.80M44.18M24.01M257.46M671.06M409.31M326.74M360.85M191.07M38.40M
Dividends Paid80.49M82.61M105.73M58.48M136.89M140.27M119.95M141.37M76.61M122.25M98.22M157.13M125.29M59.55M91.65M148.38M148.38M299.77M298.19M401.51M
FCF to OCF31.18%30.03%-64.44%58.98%59.70%-85.70%-791.50%-198.22%23.57%42.36%37.72%26.38%12.42%49.53%85.03%60.54%53.63%60.60%47.93%15.52%
Dividend Paid to FCF486.52%285.00%-455.40%94.72%147.66%-110.87%-45.33%-112.38%229.50%144.56%167.03%355.63%521.79%23.13%13.66%36.25%45.41%83.07%156.06%1045.49%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 23, 2014Oct 28, 2014Feb 13, 2015Apr 25, 2015Aug 27, 2015Oct 27, 2015Feb 27, 2016Apr 22, 2016Aug 27, 2016Oct 27, 2016Feb 24, 2017Apr 26, 2017Aug 24, 2017Oct 25, 2017Apr 25, 2018Aug 29, 2018Oct 26, 2018Feb 27, 2019Apr 24, 2019Aug 27, 2019Oct 25, 2019Feb 27, 2020Apr 24, 2020Aug 27, 2020Oct 28, 2020Apr 27, 2021Aug 24, 2021Oct 27, 2021Feb 24, 2022Apr 26, 2022Aug 25, 2022Oct 26, 2022Apr 25, 2023Aug 23, 2023Oct 25, 2023Apr 24, 2024Aug 26, 2024Oct 26, 2024Apr 23, 2025Aug 27, 2025Oct 28, 2025Apr 29, 2026Aug 28, 2026
EPS Estimate-----------------0.040.030.03-0.090.050.09---0.090.090.090.09-----------------------------
EPS Actual0.020.050.040.040.030.050.050.040.030.060.040.030.020.040.010.000.010.040.020.030.020.040.040.040.010.050.050.040.040.040.040.040.090.100.100.060.130.130.130.070.150.170.110.170.190.160.130.210.200.220.170.170.150.190.190.150.170.100.090.16
Surprise-----------------0.00%-33.33%0.00%--55.56%-20.00%-55.56%----55.56%-55.56%-55.56%-55.56%-----------------------------
Timing-----------------Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-market----

Key Statistics & Ratios

Market Cap8.55B
Enterprise Value7.63B
Trailing P/E22.15
Forward P/E28.41
Price / Sales2.22
Price / Book1.45
EPS0.39
Book Value6.14
Revenue (TTM)3.85B
Gross Profit (TTM)2.30B
EBITDA644.78M
Profit Margin10.03%
Operating Margin18.88%
Return on Equity6.66%
Return on Assets3.78%
Shares Outstanding989.20M
Shares Float751.86M
Beta0.18
Dividend Yield3.47%
Dividend Rate0.30
Payout Ratio114.45%

Dividends

20262×
0.10Sep 16, 20260.20May 28, 2026
20252×
0.10Oct 22, 20250.30May 28, 2025
20241×
0.30Jun 5, 2024
20231×
0.30Jun 2, 2023
20222×
1.08Sep 21, 20220.15Jun 8, 2022
20211×
0.15Jun 4, 2021
20201×
0.10Jun 1, 2020
20191×
0.07May 30, 2019
20181×
0.06May 30, 2018
20171×
0.07May 18, 2017
20161×
0.07May 20, 2016
20151×
0.07May 15, 2015
20131×
0.09Jun 5, 2013
20121×
0.10May 18, 2012
20111×
0.16May 11, 2011
20101×
0.13May 21, 2010

Stock Splits

  • May 18, 201715:10
  • May 8, 201415:10